We are live on ! Find out more
TTOO

T2 Biosystems, Inc
TTOO

Delisted

TTOO was delisted on the 11th of February, 2025.

Back to rankings

46 hedge funds and large institutions have $19M invested in T2 Biosystems, Inc in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more capital invested

Capital invested by funds: $7.39M → $19M (+$11.6M)

154% more call options, than puts

Call options by funds: $553K | Put options by funds: $218K

114% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 7

18% more funds holding

Funds holding: 39 → 46 (+7)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

Holders
46
Holders Change
+7
Holders Change %
+17.95%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
9
Reduced
11
Closed
7
Calls
$553K
Puts
$218K
Net Calls
+$335K
Net Calls Change
+$354K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.17M
2
BlackRock
BlackRock
New York
+$518K
3
Squarepoint
Squarepoint
New York
+$259K
4
BCM
Bridgeway Capital Management
Texas
+$212K
5
Ameriprise
Ameriprise
Minnesota
+$144K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$297K
2
GIM
Granahan Investment Management
Massachusetts
-$202K
3
UBS Group
UBS Group
Switzerland
-$76.4K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$72.2K
5
IF
Ironwood Financial
Arizona
-$63.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$48K +$34K +8 New
FWM
27
Focused Wealth Management
New York
$46K – – –
WP
28
WealthPLAN Partners
Nebraska
$40K – – –
GCP
29
GSA Capital Partners
United Kingdom
$33K -$297K -70 -93%
ML
30
McAdam LLC
Pennsylvania
$32K +$21.2K +5 New
State Street
31
State Street
Massachusetts
$28K – – –
Victory Capital Management
32
Victory Capital Management
Texas
$24K -$8.49K -2 -33%
CAI
33
Capital Advisors Inc
Oklahoma
$23K +$12.7K +3 New
US Bancorp
34
US Bancorp
Minnesota
$21K – – –
UBS Group
35
UBS Group
Switzerland
$20K -$76.4K -18 -86%
CHP
36
Cable Hill Partners
Oregon
$19K -$21.2K -5 -63%
Creative Planning
37
Creative Planning
Kansas
$18K -$21.2K -5 -63%
Cambridge Investment Research Advisors
38
Cambridge Investment Research Advisors
Iowa
$16K +$4.25K +1 +50%
Morgan Stanley
39
Morgan Stanley
New York
$15K – – –
BG
40
Bollard Group
Massachusetts
$15K +$8.49K +2 New
Bank of America
41
Bank of America
North Carolina
$14K – – –
EWM
42
Empirical Wealth Management
Washington
$14K – – –
Simplex Trading
43
Simplex Trading
Illinois
$9K -$4.25K -1 -50%
IA
44
IFP Advisors
Florida
$7K – – –
WEC
45
Winslow Evans & Crocker
Massachusetts
$7K +$4.25K +1 New
PAG
46
Private Advisor Group
New Jersey
$6K +$4.25K +1 New
KFS
47
Kelly Financial Services
Massachusetts
$2.02K – – –
FHA
48
Flagship Harbor Advisors
Massachusetts
$1K – – –
SFA
49
Semmax Financial Advisors
North Carolina
$1K – – –
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$5 – – –
1
2
3

TTOO Hedge Fund Activity: Q2 2020 in Review

46 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2020, worth a combined $19M — up 157% from $7.39M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new TTOO positions and 7 closed out — a net gain of 8 holders — while 9 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.17M. The largest seller was GSA Capital Partners, cutting an estimated $297K.

  • 46 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2020, up from 39 in Q1 2020.
  • Funds reported $19M of T2 Biosystems, Inc stock for Q2 2020, up 157% quarter-over-quarter.
  • 15 funds opened new T2 Biosystems, Inc positions in Q2 2020 and 7 closed out, a net change of +8 holders.
  • The largest T2 Biosystems, Inc buyer in Q2 2020 was Vanguard Group, an estimated $2.17M added.
  • The largest T2 Biosystems, Inc seller in Q2 2020 was GSA Capital Partners, an estimated $297K sold.

Based on aggregated 13F filings for Q2 2020.